Login to Your Account



AAIC 2017

TKIs clear toxic protein buildup and promote repair of blood-brain barrier in AD: research

By Nuala Moran
Staff Writer

Monday, July 17, 2017

LONDON – A growing body of in vitro, animal and more recently clinical research, is pointing to the potential for tyrosine kinase inhibitors (TKIs), which have established their therapeutic value in cancer, to be repurposed as treatments for Alzheimer’s and other neurodegenerative diseases.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription